feed,title,long_url,short_url
Benzinga,"TransDigm Clocks 8% Sales Growth In Q1, Misses Consensus",https://benzinga.com/news/earnings/22/02/25483641/transdigm-clocks-8-sales-growth-in-q1-misses-consensus,https://bit.ly/3GAjHH1
Benzinga,"Alpaca, Benzinga Partner Over Real-Time News APIs: 'Transparent Access To Markets'",https://benzinga.com/fintech/22/02/25468501/alpaca-benzinga-partner-over-real-time-news-apis-transparent-access-to-markets,https://bit.ly/3LfbOdL
Benzinga,Karyopharm Shares Fall After Selinexor Data In Endometrial Cancer Patients,https://benzinga.com/general/biotech/22/02/25479586/karyopharm-shares-fall-after-selinexor-data-in-endometrial-cancer-patients,https://bit.ly/360qcX5
Benzinga,Biomerica Posts Encouraging Results From InFoods Study As Irritable Bowel Syndrome Treatment,https://benzinga.com/news/22/02/25477680/biomerica-posts-encouraging-results-from-infoods-study-as-irritable-bowel-syndrome-treatment,https://bit.ly/3stttpe
